
Journal of Heterocyclic Chemistry p. 1307 - 1311 (1996)
Update date:2022-09-26
Topics:
Boyer
Fournel
Nicolai
Teulon
A new synthetic route to prepare the 2-hydroxy-5-methyl-7-n-propyl-8-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]m ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine (UP 269-6, Ripisartan) is described. UP 269-6 is a non-peptide angiotensin II antagonist currently in phase
View MoreTianjin Hedong Red Cliff Chemical Reagent Factory
Contact:+86-022-84780548
Address:Li Ming Zhuang Gong Ye Yuan,Dongli District,Tianjin,China
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Contact:86-931-8272767
Address:Room 602, No.461, Nanchang Road, Chengguan District, Lanzhou City, China PRC
ClickChem Technology Co., Limited
Contact:+86-0310-6519966/0531-52893837
Address:No.750 Shunhua Road, High-Tech Zone, Jinan city, Shandong China
website:http://www.simagchem.com
Contact:+86-592-2680277
Address:21/F Hualong Office Building,No.6 Hubin East Road, Xiamen,China
Doi:10.1021/jo01234a004
(1936)Doi:10.1021/ol403096g
(2013)Doi:10.1246/cl.1993.705
(1993)Doi:10.1039/c004547k
(2010)Doi:10.1002/hlca.19930760207
(1993)Doi:10.1021/jm981005y
(1998)